Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coby Health vs Tablet Health

Coby Health
Graded #210

Higher grade

vs+18.4
Tablet Health
Graded #495

Lower grade

The verdict

Coby Health takes it — 66/100 to 47.6/100.

Coby Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Chicago/Springfield IL DTC telehealth marketplace (Coby Health LLC, BBB file opened 3/2025) offering compounded semaglutide from $99/mo (6-mo bundle, 0.25mg) and compounded tirzepatide from $179/mo (6-mo…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoby Health +19
64
45
Dose & formulationCoby Health +3
54
51
Clinical oversightCoby Health +44
81
37
Labs & monitoringCoby Health +5
55
50
FulfillmentCoby Health +29
86
57
Contract termsEven
55
55
Coby Health · left barTablet Health · right bar

The numbers

MetricCoby HealthTablet Health
WeighScore66/10047.6/100
GradeCC
Scorecard rank#210#495
Semaglutide$159/mo (0.25 mg dose, compounded)Not disclosed
Tirzepatide$239/mo (2.5 mg dose, compounded)Not disclosed
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Coby Health

Graded #210 · C

Strengths

  • LegitScript Certified (seal 38387067)
  • No membership fee
  • Aggressive 6-month bundle pricing
  • Beluga Health P.A. clinical network — board-certified, 50-state licensure
  • Trustpilot 4.9/5 (~83 reviews)

Where it loses points

  • Does NOT publicly name compounding pharmacy partner(s) — transparency gap vs Belle/Joi+Blokes
  • Compounded medications are not FDA-approved
  • Tirzepatide pricing escalates steeply ($439/mo at 15mg monthly)
  • $50 non-refundable cancellation fee
  • No oral GLP-1 options
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard